Stocks
Health Care
rvnc
Revance Therapeutics
NASDAQ: RVNC
0.00 (0.00%)
3.65
USD
At close at Sep 04, 13:26 UTC
Income Statement
Revenue
237.08M
Gross Profit
169.27M
Operating Income
-145.85M
Pretax Income
-179.31M
Net Income
-166.85M
EBITDA
-133.54M
EBIT
-139.46M
Earnings Per Share
-1.6800000000000002
Balance Sheet
Cash & Cash Equivalents
83.25M
Total Debt
483.58M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
-138.62M
Book Value Per Share
-1.38
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.